Business Standard

US FDA nod for Pfizer's Covid-19 vaccine 'in days' after panel's support

A panel of outside advisers to the FDA on Thursday voted overwhelmingly to endorse emergency use of the vaccine, paving the way for the agency to authorize the shot

Vaccine
Premium

Pfizer has asked the two-dose vaccine, developed with German partner BioNTech, be approved for use in people aged 16 to 85

Reuters
The US Food and Drug Administration said on Friday it was working rapidly to issue an emergency use authorisation for Pfizer's Covid-19 vaccine, with the first Americans set to be immunised as early as Monday or Tuesday. US Department of Health and Human Services Secretary Alex Azar said regulatory authorisation should come within days.

A panel of outside advisers to the FDA on Thursday voted overwhelmingly to endorse emergency use of the vaccine, paving the way for the agency to authorize the shot for a country that has lost more than 285,000 lives to Covid-19.  Pfizer has asked the two-dose vaccine,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in